These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4076325)

  • 41. Changes in the pathophysiologic profile of blood pressure determinants during short-term enalapril administration.
    de Leeuw PW; Birkenhäger WH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S26-9. PubMed ID: 2422490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous administration of L-arginine inhibits angiotensin-converting enzyme in humans.
    Higashi Y; Oshima T; Ono N; Hiraga H; Yoshimura M; Watanabe M; Matsuura H; Kambe M; Kajiyama G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2198-202. PubMed ID: 7608279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are hypertensive effects of aldosterone, angiotensin, vasopressin, and norepinephrine chronically additive?
    Cowley AW; Skelton MM; Merrill DC
    Hypertension; 1986 Apr; 8(4):332-43. PubMed ID: 3514449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased systemic and renal vascular sensitivity to angiotensin II in normotensive men with positive family histories of hypertension.
    Widgren BR; Herlitz H; Aurell M; Berglund G; Wikstrand J; Andersson OK
    Am J Hypertens; 1992 Mar; 5(3):167-74. PubMed ID: 1575943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans.
    Weir MR; Klassen DK; Shen SY; Sullivan D; Buddemeyer EU; Handwerger BS
    Transplantation; 1990 Jan; 49(1):41-7. PubMed ID: 2301025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of nitric oxide in the arterial pressure and renal adaptations to long-term changes in sodium intake.
    Manning RD; Hu L; Reckelhoff JF
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1162-9. PubMed ID: 9140016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyper-responsiveness to angiotensin II is related to cardiac structural adaptation in hypertensive subjects.
    Klingbeil AU; Schobel H; Langenfeld MR; Hilgers K; Schäufele T; Schmieder RE
    J Hypertens; 1999 Jun; 17(6):825-33. PubMed ID: 10459881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Family history and pathophysiological mechanisms of primary hypertension. Studies in non-hypertensive young men with positive and negative family histories of hypertension.
    Widgren BR
    Scand J Urol Nephrol Suppl; 1991; 134():1-75. PubMed ID: 1887213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis.
    Sørensen SS; Danielsen H; Jespersen B; Pedersen EB
    Clin Nephrol; 1986 Dec; 26(6):288-96. PubMed ID: 3802595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of pinacidil on renal haemodynamics, tubular function and plasma levels of angiotensin II, aldosterone and atrial natriuretic peptide in healthy man.
    Nielsen CB; Pedersen EB
    Eur J Clin Pharmacol; 1993; 45(1):29-35. PubMed ID: 8405026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute effects of candesartan cilexetil (the new angiotensin II antagonist) on systemic and renal haemodynamics in hypertensive patients.
    Fridman K; Andersson OK; Wysocki M; Friberg P; Sunzel M
    Eur J Clin Pharmacol; 1998 Sep; 54(7):497-501. PubMed ID: 9832289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of an angiotensin II receptor antagonist, TCV-116, on renal haemodynamics in essential hypertension.
    Kawabata M; Takabatake T; Ohta H; Nakamura S; Hara H; Ohta K; Takakuwa H; Han WH; Kobayashi K
    Blood Press Suppl; 1994; 5():117-21. PubMed ID: 7889193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril.
    Atkinson AB; Davies DL; Leckie B; Morton JJ; Brown JJ; Fraser R; Lever AF; Robertson JI
    Lancet; 1979 Sep; 2(8143):606-9. PubMed ID: 90271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The acute effects of FK-506 on renal haemodynamics, water and sodium excretion and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide and vasopressin in pigs.
    Golbaekdal K; Nielsen CB; Pedersen EB
    J Pharm Pharmacol; 1996 Nov; 48(11):1174-9. PubMed ID: 8961168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relative contribution of vasopressin and angiotensin II to the altered renal microcirculatory dynamics in two-kidney Goldblatt hypertension.
    Ichikawa I; Ferrone RA; Duchin KL; Manning M; Dzau VJ; Brenner BM
    Circ Res; 1983 Nov; 53(5):592-602. PubMed ID: 6194914
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Reams GP; Bauer JH; Gaddy P
    Hypertension; 1986 Apr; 8(4):290-7. PubMed ID: 3007351
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Behavior of the renin-angiotensin-aldosterone system and vasopressin secretion in patients with renovascular hypertension or small kidney].
    Wieçek A; Kokot F
    Z Gesamte Inn Med; 1985 Mar; 40(6):172-6. PubMed ID: 3890386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Caffeine attenuates the renal vascular response to angiotensin II infusion.
    Brown NJ; Ryder D; Nadeau J
    Hypertension; 1993 Dec; 22(6):847-52. PubMed ID: 8244516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.
    Maack T; Marion DN; Camargo MJ; Kleinert HD; Laragh JH; Vaughan ED; Atlas SA
    Am J Med; 1984 Dec; 77(6):1069-75. PubMed ID: 6239544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.